Patents by Inventor Donna Klinzman

Donna Klinzman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of inducing a cross-reactive HIV-1 immune response by administering a composition comprising the GBV-C E2 protein
    Patent number: 10034936
    Abstract: GB virus C (GBV-C or hepatitis G virus) is a flavivirus that frequently leads to chronic viremia in humans. The invention provides compositions and methods involving an anti-GBV-C antibody or other GBV-C binding agent, or a GBV-C antigen, for inhibiting and treating HIV infections.
    Type: Grant
    Filed: August 15, 2014
    Date of Patent: July 31, 2018
    Assignees: The University of Iowa Research Foundation, The United States of America as represented by the Secretary of the Department of Veterans Affairs
    Inventors: Jack T. Stapleton, Jinhua Xiang, Donna Klinzman, James H. McLinden
  • GB VIRUS C (HEPATITIS G VIRUS) FOR THE TREATMENT OF HIV
    Publication number: 20140348866
    Abstract: GB virus C (GBV-C or hepatitis G virus) is a flavivirus that frequently leads to chronic viremia in humans. The invention provides compositions and methods involving an anti-GBV-C antibody or other GBV-C binding agent, or a GBV-C antigen, for inhibiting and treating HIV infections.
    Type: Application
    Filed: August 15, 2014
    Publication date: November 27, 2014
    Applicants: THE UNIVERSITY OF IOWA RESEARCH FOUNDATION, THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT
    Inventors: Jack T. STAPLETON, Jinhua XIANG, Donna KLINZMAN, James H. McLINDEN
  • Method for inhibiting HIV-1 replication utilizing anti-GBV-C E2 antibodies
    Patent number: 8858946
    Abstract: GB virus C (GBV-C or hepatitis G virus) is a flavivirus that frequently leads to chronic viremia in humans. The invention provides compositions and methods involving an anti-GBV-C antibody or other GBV-C binding agent, or a GBV-C antigen, for inhibiting and treating HIV infections.
    Type: Grant
    Filed: July 24, 2008
    Date of Patent: October 14, 2014
    Assignees: The University of Iowa Research Foundation, The United States of America, as represented by the Secretary of the Department of Veterans Affairs
    Inventors: Jack T. Stapleton, Jinhua Xiang, Donna Klinzman, James H. McLinden
  • GB VIRUS C (HEPATITIS G VIRUS) FOR THE TREATMENT OF HIV
    Publication number: 20090010932
    Abstract: GB virus C (GBV-C or hepatitis G virus) is a flavivirus that frequently leads to chronic viremia in humans. The invention provides compositions and methods involving an anti-GBV-C antibody or other GBV-C binding agent, or a GBV-C antigen, for inhibiting and treating HIV infections.
    Type: Application
    Filed: July 24, 2008
    Publication date: January 8, 2009
    Inventors: JACK T. STAPLETON, Jinhua Xiang, Donna Klinzman, James H. McLinden
  • GB virus C (hepatitis G virus) for the treatment of HIV
    Publication number: 20050118181
    Abstract: GB virus C (GBV-C or hepatitis G virus) is a flavivirus that frequently leads to chronic viremia in humans. The invention provides compositions and methods involving an anti-GBV-C antibody or other GBV-C binding agent, or a GBV-C antigen, for inhibiting and treating HIV infections.
    Type: Application
    Filed: June 4, 2004
    Publication date: June 2, 2005
    Inventors: Jack Stapleton, Jinhua Xiang, Donna Klinzman, James McLinden